Frequently Asked Questions

TMS uses FDA-approved magnetic pulses to stimulate underactive brain regions linked to depression. Treatment involves 36 sessions over 4-6 weeks with personalized coil placement and energy settings tailored to each patient. At Shore TMS, we adjust protocols based on individual response to optimize outcomes.

Spravato is a nasal esketamine therapy for Major Depressive Disorder patients who haven't responded to traditional antidepressants. It's administered under medical supervision following a structured treatment schedule. This medication-assisted approach offers an alternative for treatment-resistant cases in Eatontown, NJ and surrounding areas.

A complete TMS therapy program spans 4-6 weeks with 36 total sessions. Sessions are typically scheduled on weekdays, allowing patients to maintain work and daily routines. At Shore TMS, we design treatment schedules that balance therapeutic effectiveness with patient convenience.

Treatment resistance typically means a patient hasn't achieved adequate relief after trying two or more antidepressants at therapeutic doses. This affects many individuals with Major Depressive Disorder. Shore TMS specializes in innovative therapies like TMS and Spravato specifically designed for these medication-resistant cases.

No, TMS therapy requires in-office visits for safe administration with specialized magnetic stimulation equipment. Each session involves precise coil placement and monitoring by trained staff. However, Shore TMS offers telehealth appointments for psychiatric evaluations, consultations, and follow-up care to reduce travel needs.

Spravato is self-administered as a nasal spray under direct medical supervision in our clinic. Patients remain on-site for monitoring after administration following FDA safety protocols. The structured approach ensures patient safety while delivering effective treatment for medication-resistant depression.

Yes, a thorough psychiatric evaluation is essential to assess patient history and determine if TMS or Spravato is appropriate. At Shore TMS, Dr. Wolff conducts comprehensive evaluations to develop tailored treatment recommendations that optimize outcomes for each individual patient.

TMS uses magnetic brain stimulation delivered over 36 sessions, while Spravato is a supervised nasal medication therapy. Both target treatment-resistant depression but work through different mechanisms. Shore TMS evaluates each patient individually to determine which approach or combination offers the best potential outcome.

Most patients begin noticing mood improvements after 2-3 weeks of consistent TMS sessions, with continued progress throughout the full course. At Shore TMS, we monitor response patterns and adjust personalized coil placement and energy settings as needed to maximize therapeutic benefit.

Treatment is highly personalized based on individual patient history, symptoms, and prior medication responses. Shore TMS develops comprehensive care plans tailored to each person, adjusting TMS coil placement, energy levels, or medication protocols to achieve optimal outcomes for treatment-resistant cases.